Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transfusion Reaction | 12 | 2023 | 46 | 3.280 |
Why?
|
| Blood Transfusion | 11 | 2023 | 161 | 1.990 |
Why?
|
| Blood Safety | 6 | 2023 | 7 | 1.760 |
Why?
|
| Blood Component Removal | 7 | 2021 | 16 | 1.440 |
Why?
|
| Risk Management | 2 | 2018 | 39 | 1.100 |
Why?
|
| Checklist | 2 | 2023 | 73 | 0.960 |
Why?
|
| Students, Nursing | 2 | 2023 | 82 | 0.890 |
Why?
|
| Nursing Education Research | 1 | 2023 | 32 | 0.840 |
Why?
|
| Education, Nursing, Baccalaureate | 1 | 2023 | 43 | 0.800 |
Why?
|
| Patient Safety | 4 | 2023 | 243 | 0.770 |
Why?
|
| Blood Banks | 2 | 2023 | 9 | 0.580 |
Why?
|
| Delivery of Health Care | 3 | 2023 | 437 | 0.520 |
Why?
|
| Societies, Medical | 3 | 2021 | 373 | 0.410 |
Why?
|
| Medical Staff Privileges | 1 | 2012 | 8 | 0.400 |
Why?
|
| Blood Group Incompatibility | 2 | 2012 | 10 | 0.400 |
Why?
|
| Credentialing | 1 | 2012 | 15 | 0.400 |
Why?
|
| Medical Staff, Hospital | 1 | 2012 | 57 | 0.390 |
Why?
|
| Vital Signs | 1 | 2012 | 12 | 0.380 |
Why?
|
| Blood Volume | 1 | 2012 | 42 | 0.380 |
Why?
|
| Chlamydophila pneumoniae | 2 | 2006 | 21 | 0.320 |
Why?
|
| Plateletpheresis | 1 | 2006 | 6 | 0.260 |
Why?
|
| Humans | 26 | 2024 | 63138 | 0.250 |
Why?
|
| Telemedicine | 2 | 2021 | 323 | 0.250 |
Why?
|
| ADAMTS13 Protein | 1 | 2024 | 6 | 0.220 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2024 | 8 | 0.220 |
Why?
|
| Clinical Competence | 2 | 2023 | 724 | 0.220 |
Why?
|
| Nursing Evaluation Research | 1 | 2023 | 40 | 0.210 |
Why?
|
| Transfusion-Related Acute Lung Injury | 1 | 2023 | 1 | 0.210 |
Why?
|
| Anemia, Sickle Cell | 1 | 2022 | 63 | 0.190 |
Why?
|
| Female | 11 | 2024 | 32695 | 0.170 |
Why?
|
| Male | 9 | 2023 | 29700 | 0.170 |
Why?
|
| Adult | 8 | 2024 | 16725 | 0.160 |
Why?
|
| Acute Lung Injury | 1 | 2018 | 45 | 0.140 |
Why?
|
| Evidence-Based Nursing | 1 | 2017 | 13 | 0.140 |
Why?
|
| Critical Care Nursing | 1 | 2017 | 16 | 0.140 |
Why?
|
| United States | 4 | 2021 | 7806 | 0.130 |
Why?
|
| Blood Donors | 2 | 2006 | 23 | 0.130 |
Why?
|
| Prospective Studies | 1 | 2023 | 3267 | 0.130 |
Why?
|
| Massachusetts | 2 | 2023 | 2069 | 0.120 |
Why?
|
| Education, Medical | 1 | 2016 | 181 | 0.110 |
Why?
|
| Pulmonary Edema | 1 | 2013 | 30 | 0.100 |
Why?
|
| Anemia, Aplastic | 1 | 2013 | 10 | 0.100 |
Why?
|
| Young Adult | 1 | 2023 | 4669 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 733 | 0.100 |
Why?
|
| Algorithms | 1 | 2018 | 1001 | 0.100 |
Why?
|
| Receptor, Notch1 | 1 | 2013 | 61 | 0.100 |
Why?
|
| Consultants | 1 | 2012 | 12 | 0.100 |
Why?
|
| Physician Executives | 1 | 2012 | 28 | 0.100 |
Why?
|
| Bone Marrow | 1 | 2013 | 178 | 0.100 |
Why?
|
| Respiratory Rate | 1 | 2012 | 15 | 0.100 |
Why?
|
| Education, Medical, Continuing | 1 | 2012 | 97 | 0.090 |
Why?
|
| Fever | 1 | 2012 | 66 | 0.090 |
Why?
|
| Fluid Therapy | 1 | 2012 | 49 | 0.090 |
Why?
|
| Documentation | 1 | 2012 | 128 | 0.090 |
Why?
|
| Purpura, Thrombocytopenic | 1 | 2011 | 3 | 0.090 |
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2011 | 26 | 0.090 |
Why?
|
| Heart Rate | 1 | 2012 | 321 | 0.080 |
Why?
|
| Blood Pressure | 1 | 2012 | 510 | 0.080 |
Why?
|
| Safety | 2 | 2007 | 145 | 0.080 |
Why?
|
| Plasma Exchange | 2 | 2024 | 23 | 0.080 |
Why?
|
| Databases, Factual | 1 | 2012 | 864 | 0.070 |
Why?
|
| Inflammation | 1 | 2014 | 1145 | 0.070 |
Why?
|
| Blood Preservation | 1 | 2006 | 6 | 0.070 |
Why?
|
| Platelet Transfusion | 1 | 2006 | 11 | 0.070 |
Why?
|
| Blood Specimen Collection | 1 | 2006 | 20 | 0.070 |
Why?
|
| Automation | 1 | 2006 | 54 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 5426 | 0.060 |
Why?
|
| Heart Failure | 1 | 2013 | 912 | 0.060 |
Why?
|
| Leukocytes | 1 | 2006 | 104 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 455 | 0.060 |
Why?
|
| Safety Management | 1 | 2007 | 137 | 0.060 |
Why?
|
| Chlamydia | 1 | 2005 | 10 | 0.060 |
Why?
|
| Middle Aged | 3 | 2017 | 17463 | 0.060 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2005 | 93 | 0.060 |
Why?
|
| Quality Assurance, Health Care | 1 | 2007 | 255 | 0.060 |
Why?
|
| Chlamydia Infections | 1 | 2005 | 77 | 0.060 |
Why?
|
| Antigen-Antibody Complex | 1 | 2024 | 52 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2017 | 6590 | 0.060 |
Why?
|
| Autoantibodies | 1 | 2024 | 183 | 0.050 |
Why?
|
| Software Design | 1 | 2023 | 28 | 0.050 |
Why?
|
| Isoantibodies | 1 | 2022 | 35 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2024 | 701 | 0.050 |
Why?
|
| Technology | 1 | 2021 | 52 | 0.040 |
Why?
|
| Mobile Health Units | 1 | 2020 | 11 | 0.040 |
Why?
|
| Aged | 2 | 2017 | 14321 | 0.040 |
Why?
|
| Asthma | 1 | 2005 | 440 | 0.040 |
Why?
|
| Blood Platelets | 1 | 2021 | 101 | 0.040 |
Why?
|
| Societies, Scientific | 1 | 2019 | 36 | 0.040 |
Why?
|
| Chi-Square Distribution | 1 | 2020 | 417 | 0.040 |
Why?
|
| Risk Factors | 2 | 2019 | 5329 | 0.040 |
Why?
|
| Lung | 1 | 2023 | 945 | 0.040 |
Why?
|
| Medical Errors | 1 | 2020 | 195 | 0.040 |
Why?
|
| Babesiosis | 1 | 2014 | 12 | 0.030 |
Why?
|
| Urticaria | 1 | 2014 | 7 | 0.030 |
Why?
|
| Whooping Cough | 1 | 2014 | 10 | 0.030 |
Why?
|
| Bacterial Toxins | 1 | 2014 | 61 | 0.030 |
Why?
|
| Erythrocytes | 1 | 2014 | 149 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 176 | 0.030 |
Why?
|
| Crohn Disease | 1 | 2014 | 111 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2024 | 5621 | 0.030 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2013 | 77 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 459 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2014 | 753 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 894 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 373 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 2667 | 0.020 |
Why?
|
| Sepsis | 1 | 2014 | 286 | 0.020 |
Why?
|
| Cytokines | 1 | 2014 | 936 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2013 | 349 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 1281 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2011 | 188 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2011 | 377 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2013 | 2108 | 0.020 |
Why?
|
| Adolescent | 2 | 2011 | 6224 | 0.020 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 2007 | 11 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 2190 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 3394 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2005 | 36 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 2005 | 80 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2006 | 400 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2006 | 669 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 517 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2013 | 3034 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2005 | 1353 | 0.010 |
Why?
|
| Infant | 1 | 2005 | 1644 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2005 | 1983 | 0.010 |
Why?
|
| Mice | 1 | 2013 | 10843 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2005 | 2557 | 0.010 |
Why?
|
| Child | 1 | 2005 | 4515 | 0.010 |
Why?
|
| Animals | 1 | 2013 | 20653 | 0.010 |
Why?
|